Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1870 of 6351
-
Tiny implant could spot hidden heart risk in millions
Knowledge-focused OngoingPatients with heart failure (HF) represent a large population of patients who are at high risk for complications related to undiagnosed atrial fibrillation (AF). However, currently there are limited modalities for early AF detection and subsequent stroke prevention in this high-r…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New hope for aggressive lymphoma: drug MT-2111 under trial
Disease control Ongoing\[Phase I part\] To investigate the safety, tolerability, and pharmacokinetics of MT-2111 monotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). In addition, the dose to be used in the Phase II part will be confirmed. \[Phase II part\] To evaluat…
Phase 1/2 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New balloon treatment for heart disease tested in first human study
Disease control OngoingThis prospective, single-arm, multi-center, safety and feasibility first-in-human study will evaluate the safety and feasibility of the SirPlux Duo™ Dual-API Coated PTCA Balloon Catheter to treat de-novo lesions between ≥2.0 and ≤4.0 mm in patients with symptomatic stable angina,…
Sponsor: Advanced NanoTherapies • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Personalized walking plan may boost fitness during breast cancer chemo
Symptom relief Recruiting nowIn this study, investigators will compare standard Aerobic Training/AT with adaptive Aerobic Training/AT. Standard AT will be a fixed (unchanging) amount of walking each week, while adaptive AT will adjust the level of exercise depending on participants' response to the exercise.…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
New inhaled therapy targets lung scarring in early trial
Disease control CompletedThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of ARO-MMP7 in normal healthy volunteers (NHVs) and in participants with idiopathic pulmonary fibrosis (IPF). The study will initiate with NHVs receiving single asc…
Phase 1/2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Fat stem cells infused into kidney artery to fight transplant rejection
Disease control CompletedThis research study is being done to learn if an experimental treatment of infusing allogeneic adipose-derived mesenchymal stromal cells (allo-A-MSC ) directly into the renal artery is safe and can help reduce inflammation in the transplanted kidney and treat rejection.
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug cocktail aims to stall colorectal cancer
Disease control OngoingThis is a Phase 1b/2 study to investigate the efficacy and safety of alcestobart (LBL-007) plus tislelizumab when administered in combination with bevacizumab plus fluoropyrimidine, and alcestobart in combination with bevacizumab plus fluoropyrimidine versus bevacizumab plus fluo…
Phase 1/2 • Sponsor: BeiGene • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Prostate cancer drug showdown: which is safer for the heart?
Disease control CompletedThis was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enrollment in this study was discontinued by the Sponsor on 01 Dec 2023. In an effort to mitigate any treatment interruptions, actively e…
Phase 3 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Study tests if flexible methadone pickups keep patients in treatment
Disease control Recruiting nowUsing a stepped-wedge randomized controlled trial, the study will test whether a clinic-level multidimensional intervention conducted in 36 opioid treatment programs (OTPs) will improve clinical decision making, regulatory confusion, legal liability concerns, capacity for clinica…
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New implanted device aims to stop urgency incontinence
Disease control Recruiting nowA prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).
Sponsor: Valencia Technologies Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New RNA drug aims to reduce blood removal in polycythemia vera patients
Disease control OngoingThis is a Phase 1/2, multicenter study with an open-label dose escalation followed by a randomized placebo controlled and double-blind phase of SLN124 in adult patients with Polycythemia Vera (PV) to assess the safety, tolerability, efficacy, pharmacokinetic (PK), and Pharmacodyn…
Phase 1/2 • Sponsor: Silence Therapeutics plc • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Zapping the brain to zap migraines: new study tests 20-Day stimulation
Symptom relief Recruiting nowThis study investigates whether unilateral and bilateral non-invasive brain stimulation, given for 20 minutes/once per day for twenty days (M-F) can reduce migraine pain. Fourty patients will receive treatment (20 unilateral treatment, and 20 bilateral treatment), while twenty wi…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New dissolving stent aims to prevent dangerous leaks after pancreatic surgery
Disease control CompletedThe aim of this randomized controlled study is to compare the efficacy of biodegradable internal pancreatic stenting versus no stenting in patients undergoing pancreatoduodenectomy (PD), focusing on a possible superiority association of the device in preventing clinically relevan…
Sponsor: Ospedale San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a statin tame fatty liver disease? new trial seeks answers
Disease control OngoingThe purpose of this research study is to determine whether the study drug, atorvastatin (Lipitor®), is safe and effective in improving the features of NASH.
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New therapy aims to ease anxiety and depression in LGBTQ+ community hit by pandemic
Symptom relief OngoingThe overall aim of this program of research is to improve the mental health of people who identify as LGBTQ+ by increasing their social support through a brief intervention. The purpose of the proposed project is to establish the effectiveness of our empirically-supported, brief …
Phase 2 • Sponsor: Brown University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
MRNA shingles vaccine trial ends early – what we know
Vaccine Stopped earlyThe purpose of this clinical study is to learn about the safety, extent of the side effects (reaction to vaccine), and immune response (your immune system's reaction) of the study vaccine called Varicella Zoster Virus modRNA (VZV modRNA). We are seeking for healthy participants 5…
Phase 1/2 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 12:29 UTC
-
New heart valve shows promise in tight aortic stenosis
Disease control CompletedThe EMPIRE study confirms the technical performance of the new IMPERIA Delivery System and evaluates the safety and efficacy of the entire ALLEGRA THV System. The primary endpoint is device success rate at 7 days (discharge from index procedure or 7 days post implant, whichever …
Sponsor: NVT GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a headset at home boost memory in dementia?
Symptom relief Recruiting nowThis project aims to examine the efficacy of remote, caregiver-led tES/brain stimulation intervention targeted to improve memory, mobility, and executive functioning among older adults with mild cognitive impairment or mild dementia.
Sponsor: Hebrew SeniorLife • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Major trial aims to settle best approach for precancerous esophagus condition
Disease control Recruiting nowThe purpose of this study is to learn the best approach to treating patients with known or suspected Barrett's esophagus by comparing endoscopic surveillance to endoscopic eradication therapy. To diagnose and manage Barrett's esophagus and low-grade dysplasia, doctors commonly u…
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a good Night's sleep curb heavy drinking? new study says maybe
Symptom relief CompletedAlcohol use disorder (AUD) inflicts enormous physical, emotional, and financial burdens on the individual and society at large. Insomnia is highly prevalent among individuals with AUD, and disrupted sleep contributes substantially to alcohol-related problems. While research sugge…
Sponsor: Jessica Weafer • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC